DBD vs ADEA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

DBD

53.4
AI Score
VS
DBD Wins

ADEA

48.2
AI Score

Investment Advisor Scores

DBD

53score
Recommendation
HOLD

ADEA

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DBD ADEA Winner
Revenue 2.82B 281.08M DBD
Net Income 27.10M 42.41M ADEA
Net Margin 1.0% 15.1% ADEA
Operating Income 128.80M 69.25M DBD
ROE 2.9% 8.8% ADEA
ROA 0.7% 4.2% ADEA
Total Assets 3.66B 1.01B DBD
Debt/Equity 1.01 0.79 ADEA
Current Ratio 1.27 3.64 ADEA

Relative Price Performance (Last 90 Days)

DBD 1M: -9.4% · 3M: -20.1% ADEA 1M: -30.0% · 3M: -42.2%

Current Technical Phase

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.9%), weak momentum, RSI 38

RSI (14): 38.3 · Price: $57.34

ADEA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.8%), weak momentum, RSI 30

RSI (14): 29.8 · Price: $16.25

Fundamentals Snapshot

Metric DBD ADEA
Market Cap — —
Forward P/E 9.3 11.9
Trailing P/E 28.5 15.8
Revenue (TTM) — —
Revenue Growth 0.1% -0.1%
Gross Margin 0.3% 1.0%
Operating Margin 0.1% 0.2%
EPS 2.11 1.03
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.